The Governing Board will ensure that HCCI meets its goal of providing data that can contribute to policies that reduce health care costs, improve health care quality, increase access to care, and create a sustainable health care system. HCCI Board members include distinguished experts from the academic, actuarial, and medical communities.
Members of the Governing Board:
- Dr. Jonathan Gruber, PhD is a Professor of Economics at the Massachusetts Institute of Technology, the Director of the Health Care Program at the National Bureau of Economic Research, the co-editor of the Journal of Public Economics, and an Associate Editor of the Journal of Health Economics. Dr. Gruber served as Deputy Assistant Secretary for Economic Policy at the Treasury Department. He was a key architect of Massachusetts’ health reform effort, and in 2006 became an inaugural member of the Health Connector Board, the main implementing body for that effort. Dr. Gruber focuses his research on public finance and health economics.
- Dale H. Yamamoto, FCA, MAAA is president of his own employee benefits consulting firm and is a past president of the Conference of Consulting Actuaries. He previously chaired the 2000 Medicare Technical Review Panel and testified before Congress on a variety of health care issues. Dale has delivered speeches at a number of professional actuarial and industry meetings. He has also written several articles on health care and a textbook, “Fundamentals of Retiree Group Benefits.”
- Dr. Stephen T. Parente, PhD is the Insurance Industry Professor of Health Finance and Insurance in the Department of Finance in the Carlson School of Management at University of Minnesota. He specializes in health economics, health insurance, medical technology evaluation, and health information technology and is acknowledged as a national expert on using administrative databases, particularly Medicare and health insurer data, for health policy research.
- Dr. Leemore Dafny, PhD is the Herman Smith Research Professor in Hospital and Health Services, and a Professor of Management and Strategy, at Northwestern University’s Kellogg School of Management. During 2012-2013, Dr. Dafny was the inaugural Deputy Director for Healthcare and Antitrust in the Bureau of Economics at the Federal Trade Commission. She has served a member of the Panel of Health Advisers of the Congressional Budget Office, and is currently on the board of the American Society of Health Economists. Dr. Dafny’s research examines competitive interactions among payers and providers of healthcare services, and the intersection of industry and public policy.
- Dr. David Dranove, PhD is the Walter McNerney Professor of Health Industry Management at Northwestern University's Kellogg School of Management, where he is also Professor of Management and Strategy and Director of the Center for Health Industry Market Economics. Professor Dranove’s research focuses on problems in industrial organization and business strategy with an emphasis on the health care industry. Dr. Dranove is the recipient of the John D. Thompson Prize in Health Services Research. Professor Dranove chairs the Institute's Scientific Review Committee.
- Ted Prospect, FSA, MAAA is a Senior Vice President at the UnitedHealth Center for Health Reform and Modernization, where he oversees the development of new innovative health care products. Ted recently co-authored the Health Affairs Article: "Effective Interventions For Stemming The Growing Crisis Of Diabetes And Prediabetes: A National Payer’s Perspective". Ted was formerly a Principal at Hewitt Associates and is a Fellow of the Society of Actuaries and a Member of the American Academy of Actuaries. He earned his bachelor of science degree in applied math and business from Carnegie-Mellon University and chairs the Institute's Data Integrity Committee.
- Dr. Harvey V. Fineberg, M.D., M.P.P., Ph.D. (External Advisor to the Governing Board) is President of the Institute of Medicine. He served as Provost of Harvard University from 1997 to 2001, following thirteen years as Dean of the Harvard School of Public Health. He has devoted most of his career to the fields of health policy and medical decision-making, focusing his research primarily on the process of policy development and implementation, assessment of medical technology, evaluation and use of vaccines, and dissemination of medical innovations.
- Dr. Elizabeth G. Nabel, MD (External Advisor to the Governing Board) is the president of the Brigham and Women's/Faulkner Hospitals. Prior to her position at BWH, Dr Nabel served as the director of the National Heart, Lung, and Blood Institute at the National Institutes of Health, where she oversaw an extensive national research portfolio with an annual budget of approximately $3 billion to prevent, diagnose, and treat heart, lung, and blood diseases. Dr. Nabel is a Council member at the Institute of Medicine and a member of the Editorial Board of the New England Journal of Medicine. She is a partner on 17 patents and the author of more than 250 scientific publications.